Generic Name and Formulations:
Trimethoprim 100mg, 200mg; tabs.
Various generic manufacturers
Indications for Trimethoprim:
Treatment of initial episodes of uncomplicated UTI due to susceptible strains (E. coli, P. mirabilis, K. pneumoniae, Enterobacter species, coagulase-negative Staphylococcus species, including S. saprophyticus).
Treat for 10 days. 100mg every 12 hours or 200mg every 24 hours. CrCl 15–30mL/min: 50mg every 12 hours. CrCl<15mL/min: not recommended.
Megaloblastic anemia due to folate deficiency.
May interfere with hematopoieses (esp. when given in large doses and/or prolonged periods). Obtain CBCs if signs of serious blood disorder develop, discontinue if significant reduction in any formed blood element is found. Possible folate deficiency. Renal or hepatic impairment. Pregnancy (Cat.C). Nursing mothers.
Folic acid inhibitor.
May potentiate phenytoin. May interfere with serum methotrexate assay, Jaffe alkaline picrate reaction assay for creatinine.
Rash, pruritus, GI upset, blood dyscrasias, hyperkalemia, hyponatremia, fever, increased BUN, serum creatinine; rare: aseptic meningitis, cholestatic jaundice, hypersensitivity reactions.
Clinical Pain Advisor Articles
- Analyzing Coverage of Nonpharmacologic Treatments for Low Back Pain
- Smartphone App Helps Evaluate Catastrophizing in Chronic Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Dozens of Medical Groups Join Forces to Improve Diagnoses
- FDA Grants Non-Opioid Analgesic VVZ-149 Fast Track Status
- Little to No Association Found Between Physician Performance and Medical School Ranking